MODERN ONCO DRUG FOR INTERNAL USE
Despite the development of biotherapy, chemotherapy remains one of the main methods of treatment of cancer patients. Currently, there are more than 100 anticancer drug substances, however, every year new drugs enter clinical practice and various therapeutic regimens are tested, expanding the possibi...
Main Authors: | O. L. Orlova, L. L. Nikolaeva, L. A. Korol, M. V. Dmitrieva, A. P. Polozkova, A. V. Lantsova, I. D. Gulyakin, N. A. Oborotova |
---|---|
Format: | Article |
Language: | Russian |
Published: |
Pyatigorsk Medical and Pharmaceutical Institute - branch of Volgograd State Medical University
2018-11-01
|
Series: | Farmaciâ i Farmakologiâ (Pâtigorsk) |
Subjects: | |
Online Access: | https://www.pharmpharm.ru/jour/article/view/325 |
Similar Items
-
Marine drugs for cancer: surfacing biotechnological innovations from the oceans
by: Paula Christine Jimenez, et al.
Published: (2018-08-01) -
Variation of Cost among Anti-cancer Drugs Available in Indian Market
by: Bhanu Prakash Kolasani, et al.
Published: (2016-11-01) -
CONTRIBUTION TO THE STUDY OF THE EFFICACY AND THE MECHANISM OF ACTION OF THE ALKYLATING PEPTIDE PROLYL-m-SARCOLYSYL-p-FLUOROPHENYLALANINE (PSF)
by: Dierickx, Karen
Published: (2008) -
2-[2-(Aziridin-1-yl)ethyl]-5,5-dimethyl-2,5-dihydro-4H-benzo [e]isoindol-4-one (Cytotoxic Oxonaphthalene-Pyrroles, Part IV)
by: Helmut Spreitzer, et al.
Published: (2012-10-01) -
2-[3-(Aziridin-1-yl)-2-hydroxypropyl]-5,5-dimethyl-2,5-dihydro-4H-benzo[e]isoindol-4-one (Cytotoxic Oxonaphthalene-Pyrroles, Part III)
by: Christiane Puschmann, et al.
Published: (2012-08-01)